Morvus Technology Limited is a pharmaceutical company specialising in the discovery and commercialisation of novel drugs for the oncology market. The Company is technology-rich and has the capability to generate revenue by out-licensing a number of early-stage products whilst simultaneously progressing “blockbuster” candidates through clinical development and into patient trials. Morvus is currently preparing to enter its three lead products into clinical development.
